Felix Poppelaars

Work package 6 leader

f.poppelaars[at]umcg.nl

 

Academisch Ziekenhuis Groningen

Faculty of internal medicine

Devision of nephrology

Hanzeplein 1

9713 GZ Groningen

Netherlands

Research Gate profile

Felix.png

Felix Poppelaars is a postdoctoral fellow in the field of innate immunity at the nephrology department of the University Medical Center of Groningen (UMCG). His research focuses on the role of the complement system in chronic kidney diseases and renal replacement therapy (incl. both dialysis and renal transplantation).

Short CV

Felix Poppelaars graduated with an MD/PhD, at the University Medical Center Groningen, Netherlands. He obtained his PhD in Immunologiy and continued his postgraduate fellowship at the University of Groningen, Netherlands. He combined his postdoc with his work as a resident physician at the Martini Hospital (Groningen, Netherlands).

Relevant publications

1. Faria B, Canão P, Cai Q, Henriques C, Matos AC, Poppelaars F, Gaya da Costa M, Daha MR, Silva R, Pestana M, Seelen MA. Arteriolar C4d in IgA Nephropathy: A Cohort Study. Am J Kidney Dis. 2020 May 19:S0272-6386(20)30692-2. doi: 10.1053/j.ajkd.2020.03.017.

2.Talsma DT, Poppelaars F, Dam W, Meter-Arkema AH, Vivès RR, Gál P, Boons GJ, Chopra P, Naggi A, Seelen MA, Berger SP, Daha MR, Stegeman CA, van den Born J. MASP-2 Is a Heparin-Binding Protease; Identification of Blocking Oligosaccharides. COMBAT Consortium. Front Immunol. 2020 Apr 28;11:732. doi: 10.3389/fimmu.2020.00732.

3. Gaya da Costa M, Poppelaars F, van Kooten C, Mollnes TE, Tedesco F, Würzner R, Trouw LA, Truedsson L, Daha MR, Roos A, Seelen MA. Age and Sex-Associated Changes of Complement Activity and Complement Levels in a Healthy Caucasian Population. Front Immunol. 2018 Nov 20;9:2664. doi:10.3389/fimmu.2018.02664.

4. Poppelaars F, Gaya da Costa M, Faria B, Berger SP, Assa S, Daha MR, Medina Pestana JO, van Son WJ, Franssen CFM, Seelen MA. Intradialytic Complement Activation Precedes the Development of Cardiovascular Events in Hemodialysis Patients. Front Immunol. 2018 Sep 13;9:2070. doi: 10.3389/fimmu.2018.02070.

 

5. Hempel JC, Poppelaars F, Gaya da Costa M, Franssen CF, de Vlaam TP, Daha MR, Berger SP, Seelen MA, Gaillard CA. Distinct in vitro Complement Activation by Various Intravenous Iron Preparations. Am J Nephrol. 2017;45(1):49-59. doi: 10.1159/000451060.

 

This project has received funding from the European Union’s Horizon 2020

research and innovation programme under grant agreement No 899163

©2020 by SciFiMed.

  • Twitter
  • RESEARCH%20GATE_edited
  • LinkedIn